Petkov, Ventzislav <br/><br/>
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension.  [electronic resource] 

 -  The Journal of clinical investigation  May 2003 
 - 1339-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0021-9738 
<br/><br/><label>Standard No.: </label>10.1172/JCI17500  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cell Division--physiology<br/>Cells, Cultured<br/>Exercise<br/>Female<br/>Hemodynamics<br/>Humans<br/>Hypertension, Pulmonary--blood<br/>Immunohistochemistry<br/>Lung--metabolism<br/>Male<br/>Middle Aged<br/>Muscle, Smooth, Vascular--metabolism<br/>Myocytes, Smooth Muscle--pathology<br/>Radioligand Assay<br/>Receptors, Vasoactive Intestinal Peptide--genetics<br/>Receptors, Vasoactive Intestinal Peptide, Type II<br/>Receptors, Vasoactive Intestinal Polypeptide, Type I<br/>Vasoactive Intestinal Peptide--blood